methyl 3-(dimethylamino)-3-phenylpropionate | 220438-13-1

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: methyl 3-(dimethylamino)-3-phenylpropionate
• 英文别名: Winterstein acid methyl ester；methyl 3-N,N-dimethylamino-3-phenylpropanoate；Methyl 3-(dimethylamino)-3-phenylpropanoate
• CAS: 220438-13-1
• 化学式: C₁₂H₁₇NO₂
• 分子量: 207.272
• InChiKey: RYHXCYDXSWMMJA-UHFFFAOYSA-N

物化性质

• 沸点：
  271.3±28.0 °C(Predicted)
• 密度：
  1.037±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  15
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  29.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  methyl 3-(dimethylamino)-3-phenylpropionate 以12%的产率得到3-苯丙酸甲酯
  参考文献：
  名称：

  Appendino, Giovanni; Cravotto, Giancarlo; Gariboldi, Pierluigi, Gazzetta Chimica Italiana, 1994, vol. 124, # 1, p. 1 - 4

  摘要：

  DOI：
• 作为产物：
  描述：

  methyl 2-<(trimethylsilyl)methyl>amino-2-phenylacetate 在 potassium carbonate 、 cesium fluoride 作用下， 以 N,N-二甲基甲酰胺 、 乙腈 为溶剂， 反应 24.0h， 生成 methyl 3-(dimethylamino)-3-phenylpropionate
  参考文献：
  名称：

  Novel Isomerization Reaction of N,N-Dimethyl-α-(methoxycarbonyl)-4-substituted- benzylammonium N-Methylides

  摘要：

  Fluoride ion-induced desilylation of N,N-dimethyl-N-[(trimethylsilyl)methyl]-alpha-(methoxycarbonyl)- 4-substituted benzylammonium salts (7) gave two Stevens rearrangement products: methyl 3-(dimethylamino)-2-(4-substituted phenyl)propionates (13) from N-methylides 8, and methyl 3-(dimethylamino)-3-(4-substituted phenyl)propionates (15) from N-benzylides 10. Additional Stevens rearrangement products, methyl 2-(dimethylamino)-3-(4-substituted phenyl)propionates (16), were competitively formed from ylides 12 when the cesium fluoride used was not predried. The mechanism of the isomerization from methylides 8, which was initially generated, to 10 and 12 is discussed.

  DOI：

  10.1021/jo981729h

文献信息

• CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY
  申请人：Cerulean Pharma Inc.

  公开号：US20130196906A1

  公开（公告）日：2013-08-01

  Provided are methods relating to the use of CDP-therapeutic agent conjugates for the treatment of a disease or disorder, e.g., autoimmune disease, inflammatory disease, central nervous system disorder, cardiovascular disease, or metabolic disorder. Also provided are CDP-therapeutic agent conjugates, particles comprising CDP-therapeutic agent conjugates, and compositions comprising CDP-therapeutic agent conjugates.

  提供了关于使用CDP-治疗剂偶联物治疗疾病或紊乱的方法，例如自身免疫疾病、炎症性疾病、中枢神经系统紊乱、心血管疾病或代谢紊乱。还提供了CDP-治疗剂偶联物、包含CDP-治疗剂偶联物的颗粒以及包含CDP-治疗剂偶联物的组合物。
• [EN] PROCESSES FOR THE PREPARATION OF (+)-N,N-DIMETHYL-2-[1-(NAPHTHALENYLOXY) ETHYL] BENZENE METHANAMINE AND INTERMEDIATES THEREOF<br/>[FR] PROCÉDÉS POUR LA PRÉPARATION DE (+)-N,N-DIMÉTHYL-2-[1-(NAPHTALÉNYLOXY)ÉTHYL]BENZÈNE-MÉTHANAMINE ET INTERMÉDIAIRES DE CELLE-CI
  申请人：SYMED LABS LTD

  公开号：WO2011161690A1

  公开（公告）日：2011-12-29

  The present invention relates to processes for the preparation of S(+)-N,N-dimethyl-2-[1-(naphthalenyloxy)ethyl]benzene methanamine and intermediates thereof. More particularly the present invention relates to preparation of the compound 3(S)-(+)-N,N-dimethylamino-3-phenyl propanol useful as intermediate in the synthesis of pharmaceutically active compounds.

  本发明涉及用于制备S(+) -N,N-二甲基-2-[1-(萘氧基)乙基]苯甲胺及其中间体的过程。更具体地，本发明涉及制备化合物3(S)-(+)-N,N-二甲基氨基-3-苯基丙醇，该化合物在合成药用活性化合物中作为中间体时有用。
• B(OMe)₃as a Nonacidic Iminium Ion Generator in Mannich- and Ugi-Type Reactions
  作者：Yusuke Tanaka、Kousuke Hidaka、Tomoaki Hasui、Michinori Suginome

  DOI：10.1002/ejoc.200801190

  日期：2009.3

  Mannich-type reactions of aldehydes with secondary amines and a ketene silyl acetal were promoted by trimethoxyborane in DMSO to afford the corresponding β-amino esters in good yields. B(OMe)3 also promoted Ugi-type reactions ofaldehydes with secondary amines and isocyanides in 1,2-dichloroethane, which leads to the formation of α-amino amides. In these reactions, trimethoxyborane serves as an inexpensive

  三甲氧基硼烷在 DMSO 中促进醛与仲胺和乙烯酮甲硅烷基缩醛的曼尼希型反应，以良好的产率得到相应的 β-氨基酯。B(OMe)3 还促进醛与仲胺和异氰化物在 1,2-二氯乙烷中的 Ugi 型反应，从而形成 α-氨基酰胺。在这些反应中，三甲氧基硼烷用作廉价、市售且几乎非酸性的亚胺离子发生器。 (© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2009)
• METHODS OF TREATING A SUBJECT AND RELATED PARTICLES, POLYMERS AND COMPOSITIONS
  申请人：Fetzer Oliver S.

  公开号：US20140328918A1

  公开（公告）日：2014-11-06

  Described herein are methods for treating a subject with combinations of polymer-agent particles and cyclodextrin polymer agent conjugates. The methods herein may be used to treat subjects identified with cancer, cardiovascular disorders, autoimmune disorders, or inflammatory disorders. Also described herein are compositions, dosage forms, and kits comprising polymer-agent particles and cyclodextrin polymer agent conjugates.

  本文描述了使用聚合物-药剂颗粒和环糊精聚合物药剂偶联物的组合方法来治疗受试者。本文中的方法可用于治疗被诊断为癌症、心血管疾病、自身免疫性疾病或炎症性疾病的受试者。本文还描述了包含聚合物-药剂颗粒和环糊精聚合物药剂偶联物的组合物、剂型和套装。
• COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOIMMUNE AND OTHER DISEASES
  申请人：Cerulean Pharma Inc.

  公开号：EP3566719A1

  公开（公告）日：2019-11-13

  Provided are methods relating to the use of CDP-therapeutic agent conjugates for the treatment of autoimmune disease, inflammatory disease, or cancer. Also provided are CDP-therapeutic agent conjugates, particles comprising CDP-therapeutic agent conjugates, and compositions comprising CDP-therapeutic agent conjugates.

  本文提供了有关使用 CDP-治疗剂共轭物治疗自身免疫性疾病、炎症性疾病或癌症的方法。还提供了 CDP-治疗剂共轭物、包含 CDP-治疗剂共轭物的颗粒和包含 CDP-治疗剂共轭物的组合物。